What are the potential risks and side effects of this CAR T-cell therapy?

This is a question you may want to discuss with your doctor regarding the Autologous Bedside CD19 CAR T-cell Therapy for B-ALL clinical trial (NCT07277504). Contact the study team or your healthcare provider for specific answers.

How does this treatment compare to other options I might have?

This is a question you may want to discuss with your doctor regarding the Autologous Bedside CD19 CAR T-cell Therapy for B-ALL clinical trial (NCT07277504). Contact the study team or your healthcare provider for specific answers.

What does the treatment process look like, and how long will I need to stay in the hospital?

This is a question you may want to discuss with your doctor regarding the Autologous Bedside CD19 CAR T-cell Therapy for B-ALL clinical trial (NCT07277504). Contact the study team or your healthcare provider for specific answers.

What kind of follow-up care will I need after the treatment?

This is a question you may want to discuss with your doctor regarding the Autologous Bedside CD19 CAR T-cell Therapy for B-ALL clinical trial (NCT07277504). Contact the study team or your healthcare provider for specific answers.

Are there any specific eligibility criteria I should be aware of?

This is a question you may want to discuss with your doctor regarding the Autologous Bedside CD19 CAR T-cell Therapy for B-ALL clinical trial (NCT07277504). Contact the study team or your healthcare provider for specific answers.

How will my overall health be monitored during the trial?

This is a question you may want to discuss with your doctor regarding the Autologous Bedside CD19 CAR T-cell Therapy for B-ALL clinical trial (NCT07277504). Contact the study team or your healthcare provider for specific answers.

Finding studies

Back

Autologous Bedside CD19 CAR T-cell Therapy for B-ALL

NCT072775041 siteClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | Autologous Bedside CD19 CAR T-cell Therapy for B-ALL